Rieger, F. (2023). Trials of arsenic trioxide therapy should be envisioned for severely respiratory distress syndrome related to a cytokine storm in COVID-19 patients. Japan Journal of Research, 2(1). Retrieved from https://journals.sciencexcel.com/index.php/jjr/article/view/26